Abstract: The present invention relates to a heat-sealable structure comprising an aluminum foil and a heat-seal lacquer, said structure exhibiting a seal strength, according to ASTM F2824, of more than 23 N/15 mm when heat-sealed to another heat-sealable structure comprising an aluminum foil and the same heat-seal lacquer, the heat-seal lacquers of both structures contacting each other for heat sealing, said seal lacquer comprising a copolymer blend comprising: —from 30 to 80% by weight, preferably 40 to 70% by weight, more preferably from 50 to 60% by weight of a copolymer A based on (meth)acrylate ester (co)polymers, olefin (co)polymers and block or grafted copolymers comprising (met)acrylate ester sequences and olefin sequences, —from 20 to 70% by weight, preferably 30 to 60% by weight, more preferably from 40 to 50% by weight of a copolymer (B) based on vinyl halides, vinyl esters of carboxylic acids and ethylenically unsaturated (poly)carboxylic acids.

Abstract: The present invention relates to a heat-sealable structure comprising an aluminum foil and a heat-seal lacquer, said structure exhibiting a seal strength, according to ASTM F2824, of more than 23 N/15 mm when heat-sealed to another heat-sealable structure comprising an aluminum foil and the same heat-seal lacquer, the heat-seal lacquers of both structures contacting each other for heat sealing, said seal lacquer comprising a copolymer blend comprising: —from 30 to 80% by weight, preferably 40 to 70% by weight, more preferably from 50 to 60% by weight of a copolymer A based on (meth)acrylate ester (co)polymers, olefin (co)polymers and block or grafted copolymers comprising (met)acrylate ester sequences and olefin sequences, —from 20 to 70% by weight, preferably 30 to 60% by weight, more preferably from 40 to 50% by weight of a copolymer (B) based on vinyl halides, vinyl esters of carboxylic acids and ethylenically unsaturated (poly)carboxylic acids.

Abstract: The present invention relates to a heat-sealable structure comprising an aluminum foil and a heat-seal lacquer, said structure exhibiting a seal strength, according to ASTM F2824, of more than 23 N/15 mm when heat-sealed to another heat-sealable structure comprising an aluminum foil and the same heat-seal lacquer, the heat-seal lacquers of both structures contacting each other for heat sealing, said seal lacquer comprising a copolymer blend comprising: —from 30 to 80% by weight, preferably 40 to 70% by weight, more preferably from 50 to 60% by weight of a copolymer A based on (meth)acrylate ester (co)polymers, olefin (co)polymers and block or grafted copolymers comprising (met)acrylate ester sequences and olefin sequences, —from 20 to 70% by weight, preferably 30 to 60% by weight, more preferably from 40 to 50% by weight of a copolymer (B) based on vinyl halides, vinyl esters of carboxylic acids and ethylenically unsaturated (poly)carboxylic acids.

Abstract: The invention relates to a pharmaceutically active composition or pharmaceutical form of administering that contains at least one of the active ingredients indomethacin or acemetacin and optionally other adjuvants, the composition containing the active ingredient, or a mixture of the active ingredients, in micronized form, preferably mixed with at least one flavonoid derivative or a polypeptide or with a mixture of such compounds

Abstract: The present invention relates to a heat-sealable structure comprising an aluminum foil and a heat-seal lacquer, said structure exhibiting a seal strength, according to ASTM F2824, of more than 23 N/15mm when heat- sealed to another heat-sealable structure comprising an aluminum foil and the same heat-seal lacquer, the heat-seal lacquers of both structures contacting each other for heat sealing, said seal lacquer comprising a copolymer blend comprising: - from 30 to 80% by weight, preferably 40 to 70% by weight, more preferably from 50 to 60% by weight of a copolymer A based on (meth)acrylate ester (co)polymers, olefm (co)polymers and block or grafted copolymers comprising (met)acrylate ester sequences and olefm sequences, - from 20 to 70% by weight, preferably 30 to 60% by weight, more preferably from 40 to 50% by weight of a copolymer (B) based on vinyl halides, vinyl esters of carboxylic acids and ethylenically unsaturated (poly)carboxylic acids.

Abstract: The invention relates to a pharmaceutically active composition or pharmaceutical form of administering that contains at least one of the active ingredients indomethacin or acemetacin and optionally other adjuvants, the composition containing the active ingredient, or a mixture of the active ingredients, in micronized form, preferably mixed with at least one flavonoid derivative or a polypeptide or with a mixture of such compounds.